Cavanagh Bethany J

SVP, Finance and TreasurerBeam Therapeutics Inc. (BEAM) · full profile →Form 4 · filed Jan 21, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$91K
Net Open-Market Flow
-$91K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 20, 2026Sell(S)3K$30.12$91K41K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-017942) within minutes of acceptance. Every field above traces to the original document. Verify it directly: